Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-04-08

Clinical Trial Update: The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether soy isoflavonoids influence the cholesterol-lowering effects of soy in individuals with hyperlipidemia or cardiovascular dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy isoflavonoids (isoflavonoids)

Snippet

Sponsor: University of Toronto | Conditions: Hyperlipidemia, Cardiovascular Diseases | Phase 2 | Status: COMPLETED